Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors.
about
Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.Characterisation of immune responses in pancreatic carcinoma patients after mutant p21 ras peptide vaccinationMutational signatures: the patterns of somatic mutations hidden in cancer genomesEffect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeRAS oncogenes: weaving a tumorigenic webA comprehensive survey of Ras mutations in cancer.Sequence-directed base mispairing in human oncogenesUnderstanding the interaction between environmental exposures and molecular events in colorectal carcinogenesis.Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study.Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidyDetection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients.Ligase detection reaction for the analysis of point mutations using free-solution conjugate electrophoresis in a polymer microfluidic deviceDetection of low-abundance KRAS mutations in colorectal cancer using microfluidic capillary electrophoresis-based restriction fragment length polymorphism method with optimized assay conditionsPrognostic significance of KRAS gene mutations in colorectal cancer--preliminary study.Simultaneous detection of 19 K-ras mutations by free-solution conjugate electrophoresis of ligase detection reaction products on glass microchips.A vertically stacked, polymer, microfluidic point mutation analyzer: rapid high accuracy detection of low-abundance K-ras mutationsUpdate on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studiesDetection of K-ras Mutations in Predicting Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR-TK) Inhibitor in Patients with Metastatic Colorectal CancerPancreatic cancer after remote peptic ulcer surgerySpecific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibition of proliferation.K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell linesK-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients.K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location.The role of molecular pathology in non-small-cell lung carcinoma-now and in the future.p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system.Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer.Identification of DNA lesions using a third base pair for amplification and nanopore sequencing.Prognostic and predictive roles of KRAS mutation in colorectal cancer.Sequencing of DNA Lesions Facilitated by Site-Specific Excision via Base Excision Repair DNA Glycosylases Yielding Ligatable Gaps.Multiple mutations in the Kras gene in colorectal cancer: review of the literature with two case reports.The complexity of prostate cancer: genomic alterations and heterogeneity.Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors.Molecular fingerprints of environmental carcinogens in human cancer.Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.Ki-ras point mutations and proliferation activity in biliary tract carcinomas.Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells.Mutated Ras peptides as vaccines in immunotherapy of cancer.Maintenance of growth factor signaling through Ras in human colon carcinoma cells containing K-ras mutations.
P2860
Q21261222-E95A1CD0-AF96-4F6D-A7BB-8E3C0B434EFBQ24678848-B0C4FD8E-C43B-4440-BE8C-0594F369C6B7Q26850125-FE6A7A93-467F-45A2-8F6A-F09560AD7844Q27851703-E914BEB0-9602-4667-94F6-19B9A51FEDF7Q28250360-899AB277-9D5A-47AA-8CAF-A8330E30E100Q30416821-6875051C-75BE-44E3-83E4-8B97A36E7052Q33775489-8593F549-2021-46C5-AB08-8FBC215F7521Q34311096-FBFFAD6C-1741-4F0B-BF6B-C849EBDF6B72Q34377925-53F577A6-78AE-4486-B7E9-0ADD851FE717Q34387134-6BA21C37-E941-4000-A3C1-2DF36973AC7CQ34407468-828D29A8-0DD2-48FE-B132-7CD226299556Q34440158-9D44034A-55AD-48EC-9249-A46DF4F82332Q34565052-ABFDE106-4D2D-4CAD-A50A-1650005ED87BQ35045928-A28C0CAE-907C-413F-A758-15056F022A6FQ35180764-58D7143E-7A6C-452D-92EE-956ED3A7AB15Q35188979-5B57DD4F-9660-4845-9535-7EC1C5ED5F9AQ35573116-7E74D748-D1B2-43E3-BB8A-78D772474C8AQ35581807-2D2D697C-585A-4206-A94C-1BB4EA555274Q35586168-BE8422F1-51AC-45BC-905F-CBEBABB3E75BQ35753502-8DBA5EB6-C612-426F-AB34-80BBCA3CA6C9Q35782168-B204DBAD-BC8B-4325-AE12-FFCAE737FB9AQ35833155-75CD797E-541C-4555-85E1-5B25533A62A1Q35956330-9256D8DC-EA12-4A52-B618-75622FCB16D2Q35977674-082914E7-6915-4A6B-8B8E-A3E45499B70AQ36040599-340CE4A3-62E2-4B06-980B-C655EBA0AF80Q36107330-E270CAD9-F9AA-4872-BF46-6B66E312C1C0Q36292380-418739D1-CCF6-4CC3-8DF6-8247EFA321ADQ36292979-84C628F2-5F31-4E4B-93C1-B350FDC91594Q36341399-D6E7B6DA-CF17-4921-A544-707EBD40F4D5Q36396396-F8E93B9B-FB54-4A45-9A61-FB70E46083D2Q36790584-D38CC313-A3BF-4F40-805C-B4C03924A0C2Q37878380-E89A9E44-CA3F-47BB-B8EE-FA2C66C1D9B9Q38058243-B8D18797-FF3D-4453-954F-3BD6122E76CAQ38469522-A3CFEE32-8B3D-42EC-8F6F-441BEDC5FC6AQ38507277-E06F3DB4-E722-4059-A29A-0F547AA613B3Q39094258-B848DD37-3A62-458A-A175-59A115EFFC45Q39999643-7CF36755-E3B1-46ED-9E96-F267FD4D1E64Q40435113-4BF61FA9-08C8-46C8-97E0-CDAEEACDE2C7Q40846439-51FEF289-31EE-4157-A4FB-FE147154F79BQ41176029-16B84A33-452D-4813-BA46-A5150379E1BF
P2860
Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Frequency and spectrum of muta ...... c-K-ras gene in human tumors.
@ast
Frequency and spectrum of muta ...... c-K-ras gene in human tumors.
@en
type
label
Frequency and spectrum of muta ...... c-K-ras gene in human tumors.
@ast
Frequency and spectrum of muta ...... c-K-ras gene in human tumors.
@en
prefLabel
Frequency and spectrum of muta ...... c-K-ras gene in human tumors.
@ast
Frequency and spectrum of muta ...... c-K-ras gene in human tumors.
@en
P2093
P2860
P356
P1476
Frequency and spectrum of muta ...... c-K-ras gene in human tumors.
@en
P2093
M A Pienado
S Cronauer-Mitra
P2860
P304
P356
10.1289/EHP.9193125
P577
1991-06-01T00:00:00Z